Skip to main content
. Author manuscript; available in PMC: 2009 Aug 27.
Published in final edited form as: Pharmacogenet Genomics. 2009 Feb;19(2):161–169. doi: 10.1097/FPC.0b013e32831e030e

Table 4.

Association analysis of of APOA1/C3/A4/A5 SNPs with HDL response to fenofibratea

Phenotypic mean ± SE
SNP Alleles MAF 1/1 (n) 1/2 (n) 2/2 (n) P
APOA5_S19W C/G 0.068 0.120 ± 0.001 (2.72 ± 5.70) (763) 0.117 ± 0.002 (4.49 ± 5.48) (95) 0.096 ± 0.006 (6.66 ± 4.72) (3) 0.002b
APOA5_M1123 G/A 0.062 0.120 ± 0.001 (762) 0.116 ± 0.003 (97) 0.117 ± 0.002 (2) 0.270
APOA4_A5INTER C/T 0.353 0.120 ± 0.003 (370) 0.121 ± 0.001 (395) 0.119 ± 0.001 (96) 0.510
APOA4_T347S A/T 0.183 0.120 ± 0.001 (588) 0.120 ± 0.001 (245) 0.118 ± 0.006 (28) 0.947
APOA4_N147S G/A 0.130 0.119 ± 0.001 (656) 0.122 ± 0.002 (189) 0.122 ± 0.007 (16) 0.487
APOA4_T29T G/A 0.173 0.119 ± 0.001 (591) 0.121 ± 0.001 (249) 0.122 ± 0.006 (21) 0.553
APOA4_M35 C/G 0.051 0.120 ± 0.001 (781) 0.117 ± 0.003 (80) 0.325
APOC3_M2886 C/A 0.348 0.121 ± 0.002 (382) 0.121 ± 0.001 (382) 0.119 ± 0.001 (97) 0.502
APOC3_M640 A/C 0.360 0.118 ± 0.001 (368) 0.121 ± 0.001 (392) 0.121 ± 0.002 (98) 0.273
APOC3_M482 A/G 0.250 0.124 ± 0.004 (505) 0.120 ± 0.001 (306) 0.119 ± 0.001 (46) 0.441
APOC3_M455 G/A 0.356 0.120 ± 0.002 (376) 0.121 ± 0.001 (391) 0.119 ± 0.001 (94) 0.468
APOC3_G34G T/C 0.262 0.119 ± 0.001 (480) 0.121 ± 0.001 (318) 0.120 ± 0.004 (63) 0.772
APOC3_3U386 C/G 0.094 0.120 ± 0.001 (718) 0.118 ± 0.002 (138) 0.135 ± 0.012 (5) 0.354
APOA1_M75 A/G 0.160 0.118 ± 0.001 (603) 0.122 ± 0.001 (226) 0.125 ± 0.006 (32) 0.216
APOA1_M2630 A/G 0.292 0.122 ± 0.003 (433) 0.122 ± 0.001 (359) 0.118 ± 0.001 (69) 0.112
APOA1_M2803 G/A 0.353 0.118 ± 0.001 (374) 0.122 ± 0.001 (389) 0.120 ± 0.002 (98) 0.132
APOA1_M3012 A/G 0.128 0.120 ± 0.008 (657) 0.122 ± 0.002 (181) 0.119 ± 0.001 (21) 0.355

Numbers in brackets are absolute changes of HDL (mg/dl) in response to fenofibrate. Bold italic indicates minor alleles. P values less than 0.05 are shown in boldface.

MAF, minor allele frequency; SNP, single nucleotide polymorphism; HDL, high-density lipoprotein.

a

Response to fenofibrate (phenotype) was represented by slope estimated from growth curve models.

b

Indicates significant associations after Bonferroni’s correction. The significance threshold is P < 0.003 (0.05/17).